Jeffrey G. Lamothe - Aug 8, 2023 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
EVP, COO
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
Stock symbol
APVO
Transactions as of
Aug 8, 2023
Transactions value $
$0
Form type
4
Date filed
8/10/2023, 08:41 AM
Previous filing
Mar 7, 2023
Next filing
Jan 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APVO Common Stock Options Exercise +12K +94.38% 24.7K Aug 8, 2023 Direct F1
transaction APVO Common Stock Options Exercise +1.83K +7.43% 26.5K Aug 8, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Restricted Stock Unit Options Exercise $0 -12K -50% $0.00 12K Aug 8, 2023 Common Stock 12K Direct F1, F2
transaction APVO Restricted Stock Unit Options Exercise $0 -1.83K -33.33% $0.00 3.67K Aug 8, 2023 Common Stock 1.83K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2 On August 9, 2022, the reporting person was granted 23,958 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.
F3 On August 9, 2022, the reporting person was granted 5,500 RSUs, vesting in three approximately equal installments beginning on August 8, 2023.